5-157731431-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_ModerateBP6BA1
The NM_017872.5(THG1L):c.-10C>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.152 in 1,577,552 control chromosomes in the GnomAD database, including 19,725 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.11 ( 1338 hom., cov: 31)
Exomes 𝑓: 0.16 ( 18387 hom. )
Consequence
THG1L
NM_017872.5 5_prime_UTR
NM_017872.5 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.84
Genes affected
THG1L (HGNC:26053): (tRNA-histidine guanylyltransferase 1 like) The protein encoded by this gene is a mitochondrial protein that is induced by high levels of glucose and is associated with diabetic nephropathy. The encoded protein appears to increase mitochondrial biogenesis, which could lead to renal fibrosis. Another function of this protein is that of a guanyltransferase, adding GMP to the 5' end of tRNA(His). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.35).
BP6
Variant 5-157731431-C-A is Benign according to our data. Variant chr5-157731431-C-A is described in ClinVar as [Benign]. Clinvar id is 3059739.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.223 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
THG1L | NM_017872.5 | c.-10C>A | 5_prime_UTR_variant | 1/6 | ENST00000231198.12 | NP_060342.2 | ||
THG1L | NM_001317824.2 | c.-311C>A | 5_prime_UTR_variant | 1/6 | NP_001304753.1 | |||
THG1L | NM_001317825.2 | c.-381C>A | 5_prime_UTR_variant | 1/6 | NP_001304754.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
THG1L | ENST00000231198.12 | c.-10C>A | 5_prime_UTR_variant | 1/6 | 1 | NM_017872.5 | ENSP00000231198 | P1 | ||
THG1L | ENST00000521655.1 | c.-10C>A | 5_prime_UTR_variant, NMD_transcript_variant | 1/6 | 2 | ENSP00000428387 |
Frequencies
GnomAD3 genomes AF: 0.115 AC: 17478AN: 152006Hom.: 1334 Cov.: 31
GnomAD3 genomes
AF:
AC:
17478
AN:
152006
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.142 AC: 31641AN: 222780Hom.: 2690 AF XY: 0.150 AC XY: 17798AN XY: 118758
GnomAD3 exomes
AF:
AC:
31641
AN:
222780
Hom.:
AF XY:
AC XY:
17798
AN XY:
118758
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.156 AC: 221931AN: 1425428Hom.: 18387 Cov.: 31 AF XY: 0.158 AC XY: 111220AN XY: 705264
GnomAD4 exome
AF:
AC:
221931
AN:
1425428
Hom.:
Cov.:
31
AF XY:
AC XY:
111220
AN XY:
705264
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.115 AC: 17484AN: 152124Hom.: 1338 Cov.: 31 AF XY: 0.115 AC XY: 8579AN XY: 74368
GnomAD4 genome
AF:
AC:
17484
AN:
152124
Hom.:
Cov.:
31
AF XY:
AC XY:
8579
AN XY:
74368
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
741
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
THG1L-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 20, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at